ENTPD1 and B-cell chronic lymphocytic leukemia: During our analyses to identify the underlying mechanisms, we found that CLL-EVs harbor a multifaceted palette of immunological checkpoints (ICs) including CD39, CD73, PD-L1, TGFβ, Gal9, and CD112 (Figure 5D, Supplementary Figure S4A,B).